Advertisement
Advertisement
ANTX
AN2 Therapeutics, Inc. Common Stock
4.89
USDSponsored
+0.06
+1.24%
Sep 24, 15:59 UTC -4
Closed
Pre-Market
4.92
+0.03
+0.59%
AN2 Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 185.62M |
| Beta | -0.99 |
| Earnings Per Share (EPS) | -1.07 |
| Price-to-Book (P/B) Ratio | 2.29 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -53.52% |
| Current Ratio | 14.32% |
| Free Cash Flow | -19.07M |
